Noninvasive Submental Fat Compartment Treatment

Background: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration-approved injectable drug for the reduction of submental fat. Objectives: A literature review and discussion of the treatment of submental fat. Results: KYBELLA is a well-tolerated alternative for the treatment of submental fat. Conclusions: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat. Copyright (C) 2016 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons. All rights reserved.

http://ift.tt/2igi5ec